FdaApplication
ANDA 210105
Identifiers
- fda_app_no: ANDA210105
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS OF NY LLC |
| application_type | ANDA |
| approval_date | 2018-09-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BEXAROTENE | BEXAROTENE | 75MG | CAPSULE;ORAL |
1 product